Literature DB >> 27146040

Scoring system to preoperatively predict choledocholithiasis.

Sheshang U Kamath1, Satish B Dharap2, Vineet Kumar2.   

Abstract

BACKGROUND: The incidence of common bile duct (CBD) calculi has been reported to be 8 % to 20 % among the patients with cholelithiasis. Failure to detect CBD stones on the part of the surgeon not only fails to relieve symptoms but also subjects them to potentially life-threatening complications such as cholangitis, pancreatitis or obstructive jaundice. Modalities for detection of CBD stones have evolved over time from CBD exploration based on clinical and operative findings to intraoperative cholangiography (IOC), to endoscopic retrograde cholangiopancreaticography (ERCP) and, recently, to magnetic resonance cholangiopancreaticography (MRCP) and endoscopic ultrasonography (EUS). We felt a need for a scoring system to predict a patient population having a higher risk of choledocholithiasis so that these modern interventions can be selectively utilized.
SETTING: This study was performed in a tertiary care medical college hospital in a metropolitan city.
DESIGN: This is a prospective observational study.
METHODS: All patients with symptomatic cholelithiasis admitted to the hospital were included. Patients were diagnosed as having choledocholithiasis either by ultrasonography (USG), computed tomography scan, MRCP, EUS or ERCP and were followed up for at least 6 weeks.
RESULTS: The prevalence of choledocholithiasis among the 275 patients with symptomatic biliary colic in our study was 18.9 % (n = 77). On bivariate analysis, dilated bile duct on USG (>6 mm), raised total bilirubin, raised alkaline phosphatase (ALP), raised amylase, raised SGPT and SGOT were significantly associated with choledocholithiasis (p < 0.05). On multivariate analysis also, all these factors except amylase and SGPT showed a significant correlation with choledocholithiasis (p < 0.05). These observations were used to build a scoring system consisting of four factors: dilated bile duct on USG (>6 mm), total bilirubin >2 mg/dL, ALP >190 IU/L and SGOT >40 IU/L.
CONCLUSION: A positive predictive value of 3 or more factors was over 95 %, necessitating an endoscopic intervention. A negative predictive value of the absence of any factor was 100 %, which ruled out CBD calculi. If only one or two factors are positive, then further evaluation is recommended preferably using non-minimal or minimal invasive investigations like EUS or MRCP.

Entities:  

Keywords:  Cholecystectomy; Choledocholithiasis; ERCP; Predictive factors

Mesh:

Substances:

Year:  2016        PMID: 27146040     DOI: 10.1007/s12664-016-0655-y

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  14 in total

1.  A prospective study of common bile duct calculi in patients undergoing laparoscopic cholecystectomy: natural history of choledocholithiasis revisited.

Authors:  Chris Collins; Donal Maguire; Adrian Ireland; Edward Fitzgerald; Gerald C O'Sullivan
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

2.  Randomised trial of laparoscopic exploration of common bile duct versus postoperative endoscopic retrograde cholangiography for common bile duct stones.

Authors:  M Rhodes; L Sussman; L Cohen; M P Lewis
Journal:  Lancet       Date:  1998-01-17       Impact factor: 79.321

3.  Validation and improvement of a proposed scoring system to detect retained common bile duct stones in gallstone pancreatitis.

Authors:  Jingjing L Sherman; Emily W Shi; Nalin E Ranasinghe; Muthu T Sivasankaran; Jake G Prigoff; Celia M Divino
Journal:  Surgery       Date:  2015-02-21       Impact factor: 3.982

4.  Indications, clinical value and complications of endoscopic retrograde cholangiopancreatography.

Authors:  R E Kessler; D B Falkenstein; A R Clemett; D S Zimmon
Journal:  Surg Gynecol Obstet       Date:  1976-06

5.  Predictors of common bile duct lithiasis in laparoscopic era.

Authors:  George Sgourakis; Georgia Dedemadi; Athanasios Stamatelopoulos; Emmanuel Leandros; Dionysius Voros; Konstantinos Karaliotas
Journal:  World J Gastroenterol       Date:  2005-06-07       Impact factor: 5.742

6.  Prediction of common bile duct stones by noninvasive tests.

Authors:  F Prat; B Meduri; B Ducot; R Chiche; R Salimbeni-Bartolini; G Pelletier
Journal:  Ann Surg       Date:  1999-03       Impact factor: 12.969

7.  Biochemical predictors for absence of common bile duct stones in patients undergoing laparoscopic cholecystectomy.

Authors:  Ming-Hsun Yang; Tien-Hua Chen; Shin-E Wang; Yi-Fang Tsai; Cheng-Hsi Su; Chew-Wun Wu; Wing-Yiu Lui; Yi-Ming Shyr
Journal:  Surg Endosc       Date:  2007-11-14       Impact factor: 4.584

8.  Preoperative clinical and paraclinical predictors of choledocholithiasis.

Authors:  Ali Yaghoobi Notash; Javad Salimi; Farzaneh Golfam; Gholamreza Habibi; Kamyab Alizadeh
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2008-06

9.  For patients with predicted low risk for choledocholithiasis undergoing laparoscopic cholecystectomy, selective intraoperative cholangiography and postoperative endoscopic retrograde cholangiopancreatography is an effective strategy to limit unnecessary procedures.

Authors:  Michael F Byrne; Mark T McLoughlin; Robert M Mitchell; Henning Gerke; K Kim; Theodore N Pappas; M S Branch; Paul S Jowell; John Baillie
Journal:  Surg Endosc       Date:  2008-12-31       Impact factor: 4.584

10.  Predictor factors for choledocholithiasis.

Authors:  Joana Tozatti; André Luiz Parizi Mello; Orli Frazon
Journal:  Arq Bras Cir Dig       Date:  2015 Apr-Jun
View more
  2 in total

1.  Combination of CT findings can reliably predict radiolucent common bile duct stones: a novel approach using a CT-based nomogram.

Authors:  Ji Hye Min; Kyung Sook Shin; Jeong Eun Lee; Seo-Youn Choi; Soohyun Ahn
Journal:  Eur Radiol       Date:  2019-05-21       Impact factor: 5.315

Review 2.  Systematic review and meta-analysis of the 2010 ASGE non-invasive predictors of choledocholithiasis and comparison to the 2019 ASGE predictors.

Authors:  Louie Wang; Sarah Mirzaie; Tavit Dunnsiri; Formosa Chen; Holly Wilhalme; Ian T MacQueen; Henry Cryer; Anaar Eastoak-Siletz; Michelle Guan; Callie Cuff; James H Tabibian
Journal:  Clin J Gastroenterol       Date:  2022-01-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.